Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Amgen and Roche extend EU collaboration on G-CSF products

April 16, 1997

Optimal dose of sertraline for premature ejaculation

April 16, 1997

Esters of estrogenic compounds from Lilly

April 16, 1997

Norian seeks FDA approval for orthopedic applications of Norian SRS

April 15, 1997

Nitrosylated alpha-adrenoceptor antagonists for erectile dysfunction

April 15, 1997

Melanotropic peptide effective in men with erectile dysfunction

April 15, 1997

Moxisylyte recommended as first-line therapy for erectile dysfunction

April 15, 1997

Transurethral alprostadil/prazosin for erectile dysfunction

April 15, 1997

Fluoxetine for the management of premature ejaculation

April 15, 1997

Lilly reports compounds for postmenopausal syndrome

April 15, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 5, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
Study identifies CAND1 as therapeutic target in hepatoblastoma
BioWorld Science
Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a...